Targeted epigenetic reactivation of dormant tumor suppressors: New precision therapies for liver cancer

Blancafort, Pilar (Chief Investigator)
Swaminatha Iyer, Killugudi (Investigator 02)
Yeoh, George (Investigator 03)
Cursons, Joseph (Investigator 04)

Status	Active
Effective start/end date	1/01/19 → 31/12/22

Funding

National Health & Medical Research Council NHMRC: A$291,688.00
National Health & Medical Research Council NHMRC: A$286,688.00
National Health & Medical Research Council NHMRC: A$221,936.00
National Health & Medical Research Council NHMRC: A$339,148.00

Access Project

http://purl.org/au-research/grants/nhmrc/1165208

4 Article
1 Review article

Epigenome engineering: new technologies for precision medicine
Sgro, A. & Blancafort, P., 16 Dec 2020, In: Nucleic Acids Research. 48, 22, p. 12453-12482 30 p.
Research output: Contribution to journal › Article › peer-review

Open Access
9 Citations (Web of Science)
Honeybee venom and melittin suppress growth factor receptor activation in HER2-enriched and triple-negative breast cancer
Duffy, C., Sorolla, A., Wang, E., Golden, E., Woodward, E., Davern, K., Ho, D., Johnstone, E., Pfleger, K., Redfern, A., Iyer, K. S., Baer, B. & Blancafort, P., 1 Dec 2020, In: npj Precision Oncology. 4, 1, 16 p., 24.
Research output: Contribution to journal › Article › peer-review

Open Access
41 Citations (Web of Science)
Innovative Precision Gene-Editing Tools in Personalized Cancer Medicine
Dai, X., Blancafort, P., Wang, P., Sgro, A., Thompson, E. W. & Ostrikov, K., 1 Jun 2020, In: Advanced Science. 7, 12, 1902552.
Research output: Contribution to journal › Article › peer-review

Open Access
5 Citations (Scopus)